Overview
To observe the clinical effects and make a comparative study between efficacy of electrical pudendal nerve stimulation (EPNS) and sacral neuromodulation (SNM) , evaluate the advantages of EPNS in the treatment of neurogenic non-obstructive urinary retention, and provide a new method for the treatment of the disease.
Eligibility
Inclusion Criteria:
- Non-mechanical obstructive urinary retention occurs following relevant neurological system disorders (spinal cord injury, spina bifida,myelitis, cervical/thoracic disk disease, lesion following spinal anesthesia/spine surgery,lumbar/sacral spine intervertebral disc diseases, spinal stenosis, iatrogenic pelvic nerve lesions, sacral agenesis, peripheral neuropathy due to diabetes mellitus).
- With normal upper urinary tract function.
- Other therapies and medications potentially affecting the assessment of this therapy have been discontinued for at least two weeks before the interventional procedure.
- Patient with good compliance who is capable of cooperating with the follow-up requirements
Exclusion Criteria:
- Patients with any suprapontine and pontine lesions
- Pregnant or lactating women
- Individuals whose symptoms show significant improvement after pharmaceutical and adjunctive therapy
- Individuals with concurrent acute or chronic prostatitis, prostate cancer, or conditions such as bladder neck stenosis, urethral stricture, or urethral injury
- High pathological risk factors (e.g., lymph node metastasis, resection margin involvement, bulky tumors)
- Individuals with concomitant obstructive urinary retention